Breaking News

INSP

Inspire Medical

27
Apr

02/08/23 Lake Street: Inspire Medical price target raised to $305 from $250 at Lake Street

02/08/23 Truist: Inspire Medical price target raised to $330 from $310 at Truist

02/08/23 Piper Sandler: Inspire Medical price target raised to $305 from $300 at Piper Sandler

01/31/23 Truist: Inspire Medical price target raised to $310 from $308 at Truist

Clear This Search Refresh Search

Tuesday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	Inspire Medical announces FDA approval for pediatric patients with Down Syndrome » 08:09 03/21/23 03/21 08:09 03/21/23 08:09 INSP Inspire Medical $247.86 / +0.79 (+0.32%) Inspire Medical Systems… Inspire Medical Systems announced that it has received approval from the Food and Drug Administration, FDA, to offer Inspire therapy to pediatric patients with Down syndrome. "Since our first FDA approval in 2014, the research team at Mass Eye and Ear, led by Dr. Christopher Hartnick, have pioneered the use of Inspire in this important group of people and we are thrilled to announce this most impactful approval on World Down Syndrome Day," said Tim Herbert, President and Chief Executive Officer of Inspire. "We acknowledge and appreciate the persistence of Dr. Hartnick's team, as well as the teams at the many participating institutions, to collect the necessary clinical evidence to support the FDA approval. We would also like to thank the LuMind IDSC Down Syndrome Foundation for their support of our FDA application. Inspire intends to immediately begin educating healthcare providers across the U.S. about the benefits of Inspire therapy for children with Down syndrome." Inspire has been prescribed to adults with Down syndrome for several years, but previously only to patients who were at least 18 years of age. Approval of the pediatric population with Down syndrome will include OSA patients who are at least 13 years old, with an apnea hypopnea index between 10 and 50, and do not have the ability to benefit from CPAP. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $247.86 / +0.79 (+0.32%) 03/09/23 Inspire Medical receives countrywide reimbursement approval in Belgium 12/20/22 Inspire Medical publishes inaugural ESG summary report INSP Inspire Medical $247.86 / +0.79 (+0.32%) 02/08/23 Lake Street Inspire Medical price target raised to $305 from $250 at Lake Street 02/08/23 Truist Inspire Medical price target raised to $330 from $310 at Truist 02/08/23 Piper Sandler Inspire Medical price target raised to $305 from $300 at Piper Sandler 01/31/23 Truist Inspire Medical price target raised to $310 from $308 at Truist INSP Inspire Medical $247.86 / +0.79 (+0.32%) 02/07/23 Inspire Medical reports Q4 EPS 10c, consensus (57c) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 12 Aug INSP Inspire Medical $247.86 / +0.79 (+0.32%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/21/23 Life Sciences & MedTech Virtual Investor Forum 04/27/23 Inspire Medical Systems, Inc.

Over a week ago
Hot Stocks	Inspire Medical receives countrywide reimbursement approval in Belgium » 17:25 03/09/23 03/09 17:25 03/09/23 17:25 INSP Inspire Medical $243.07 / -10.46 (-4.13%) Inspire Medical announced… Inspire Medical announced that it has received countrywide reimbursement approval in Belgium, effective immediately, at rates consistent with other countries around the world. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly INSP Inspire Medical $243.07 / -10.46 (-4.13%) 12/20/22 Inspire Medical publishes inaugural ESG summary report 09/14/22 Inspire Medical announces updates from ISSS, AAO-HNSF meetings INSP Inspire Medical $243.07 / -10.46 (-4.13%) 02/08/23 Lake Street Inspire Medical price target raised to $305 from $250 at Lake Street 02/08/23 Truist Inspire Medical price target raised to $330 from $310 at Truist 02/08/23 Piper Sandler Inspire Medical price target raised to $305 from $300 at Piper Sandler 01/31/23 Truist Inspire Medical price target raised to $310 from $308 at Truist INSP Inspire Medical $243.07 / -10.46 (-4.13%) 02/07/23 Inspire Medical reports Q4 EPS 10c, consensus (57c) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 12 Aug INSP Inspire Medical $243.07 / -10.46 (-4.13%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Conference/Events	Inspire Medical management to meet with Truist » 04:55 03/02/23 03/02 04:55 03/02/23 04:55 INSP Inspire Medical $263.70 / +3.695 (+1.42%) Meetings to be held in… Meetings to be held in New York March 1-2 hosted by Truist. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $263.70 / +3.695 (+1.42%) 12/20/22 Inspire Medical publishes inaugural ESG summary report 09/14/22 Inspire Medical announces updates from ISSS, AAO-HNSF meetings INSP Inspire Medical $263.70 / +3.695 (+1.42%) 02/08/23 Lake Street Inspire Medical price target raised to $305 from $250 at Lake Street 02/08/23 Truist Inspire Medical price target raised to $330 from $310 at Truist 02/08/23 Piper Sandler Inspire Medical price target raised to $305 from $300 at Piper Sandler 01/31/23 Truist Inspire Medical price target raised to $310 from $308 at Truist INSP Inspire Medical $263.70 / +3.695 (+1.42%) 02/07/23 Inspire Medical reports Q4 EPS 10c, consensus (57c) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 12 Aug INSP Inspire Medical $263.70 / +3.695 (+1.42%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/02/23 Inspire Medical
Conference/Events	Inspire Medical management to meet with Truist » 09:15 03/01/23 03/01 09:15 03/01/23 09:15 INSP Inspire Medical $259.92 / -3.9301 (-1.49%) Meetings to be held in… Meetings to be held in New York March 1-2 hosted by Truist. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $259.92 / -3.9301 (-1.49%) 12/20/22 Inspire Medical publishes inaugural ESG summary report 09/14/22 Inspire Medical announces updates from ISSS, AAO-HNSF meetings INSP Inspire Medical $259.92 / -3.9301 (-1.49%) 02/08/23 Lake Street Inspire Medical price target raised to $305 from $250 at Lake Street 02/08/23 Truist Inspire Medical price target raised to $330 from $310 at Truist 02/08/23 Piper Sandler Inspire Medical price target raised to $305 from $300 at Piper Sandler 01/31/23 Truist Inspire Medical price target raised to $310 from $308 at Truist INSP Inspire Medical $259.92 / -3.9301 (-1.49%) 02/07/23 Inspire Medical reports Q4 EPS 10c, consensus (57c) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 12 Aug INSP Inspire Medical $259.92 / -3.9301 (-1.49%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/01/23 Inspire Medical 03/02/23 Inspire Medical

Over a month ago
Recommendations	Inspire Medical price target raised to $305 from $250 at Lake Street » 09:17 02/08/23 02/08 09:17 02/08/23 09:17 INSP Inspire Medical $249.33 / +5.91 (+2.43%) Lake Street analyst Frank… Lake Street analyst Frank Takkinen raised the firm's price target on Inspire Medical to $305 from $250 and keeps a Buy rating on the shares, stating that the company "performed superbly" in its "seasonally strongest quarter of the year." Inspire "remains in the early innings" as indicated by the expectation for continued outsized growth and 2023 year-over-year growth guidance of 37%-40%, Lake Street added. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $249.33 / +5.91 (+2.43%) 12/20/22 Inspire Medical publishes inaugural ESG summary report 09/14/22 Inspire Medical announces updates from ISSS, AAO-HNSF meetings 08/15/22 Inspire Medical appoints Ezgi Yagci as VP, investor relations INSP Inspire Medical $249.33 / +5.91 (+2.43%) 02/08/23 Truist Inspire Medical price target raised to $330 from $310 at Truist 02/08/23 Piper Sandler Inspire Medical price target raised to $305 from $300 at Piper Sandler 01/31/23 Truist Inspire Medical price target raised to $310 from $308 at Truist 01/31/23 Lake Street CVRx initiated with a Buy at Lake Street INSP Inspire Medical $249.33 / +5.91 (+2.43%) 02/07/23 Inspire Medical reports Q4 EPS 10c, consensus (57c) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 12 Aug INSP Inspire Medical $249.33 / +5.91 (+2.43%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/01/23 Inspire Medical 03/02/23 Inspire Medical
Recommendations	Inspire Medical price target raised to $330 from $310 at Truist » 07:45 02/08/23 02/08 07:45 02/08/23 07:45 INSP Inspire Medical $249.33 / +5.91 (+2.43%) Truist analyst Richard… Truist analyst Richard Newitter raised the firm's price target on Inspire Medical to $330 from $310 and keeps a Buy rating on the shares. The company's Q4 marked a "solid beat" and its outlook likely leaves room for upside, the analyst tells investors in a research note, also noting that the stock remains the firm's top FY23 pick. The firm adds that Inspire's monthly its total addressable market. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $249.33 / +5.91 (+2.43%) 12/20/22 Inspire Medical publishes inaugural ESG summary report 09/14/22 Inspire Medical announces updates from ISSS, AAO-HNSF meetings 08/15/22 Inspire Medical appoints Ezgi Yagci as VP, investor relations INSP Inspire Medical $249.33 / +5.91 (+2.43%) 02/08/23 Piper Sandler Inspire Medical price target raised to $305 from $300 at Piper Sandler 01/31/23 Truist Inspire Medical price target raised to $310 from $308 at Truist 01/31/23 Lake Street CVRx initiated with a Buy at Lake Street 01/26/23 Piper Sandler Inspire Medical price target raised to $300 from $285 at Piper Sandler INSP Inspire Medical $249.33 / +5.91 (+2.43%) 02/07/23 Inspire Medical reports Q4 EPS 10c, consensus (57c) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 12 Aug INSP Inspire Medical $249.33 / +5.91 (+2.43%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/01/23 Inspire Medical 03/02/23 Inspire Medical
Recommendations	Inspire Medical price target raised to $305 from $300 at Piper Sandler » 04:30 02/08/23 02/08 04:30 02/08/23 04:30 INSP Inspire Medical $249.33 / +5.91 (+2.43%) Piper Sandler analyst… Piper Sandler analyst Adam Maeder raised the firm's price target on Inspire Medical to $305 from $300 and keeps an Overweight rating on the shares. The company reported Q4 results with sales at the high-end of the preannouncement and earnings materially better than forecasts, the analyst tells investors in a research note. Piper says Inspire "brings substantial momentum into the new year" and it continues to view the stock as its favorite name in 2023. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $249.33 / +5.91 (+2.43%) 12/20/22 Inspire Medical publishes inaugural ESG summary report 09/14/22 Inspire Medical announces updates from ISSS, AAO-HNSF meetings 08/15/22 Inspire Medical appoints Ezgi Yagci as VP, investor relations INSP Inspire Medical $249.33 / +5.91 (+2.43%) 01/31/23 Truist Inspire Medical price target raised to $310 from $308 at Truist 01/31/23 Lake Street CVRx initiated with a Buy at Lake Street 01/26/23 Piper Sandler Inspire Medical price target raised to $300 from $285 at Piper Sandler 12/13/22 Goldman Sachs Inspire Medical upgraded to Buy, named top Medtech midcap at Goldman Sachs INSP Inspire Medical $249.33 / +5.91 (+2.43%) 02/07/23 Inspire Medical reports Q4 EPS 10c, consensus (57c) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 12 Aug INSP Inspire Medical $249.33 / +5.91 (+2.43%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/01/23 Inspire Medical 03/02/23 Inspire Medical
Earnings	Inspire Medical reports Q4 EPS 10c, consensus (57c) » 16:10 02/07/23 02/07 16:10 02/07/23 16:10 INSP Inspire Medical $249.92 / +6.5 (+2.67%) Reports Q revenue… Reports Q revenue $137.9M, consensus $129.26M.Net income was $3.2M for the fourth quarter of 2022, as compared to a loss of $2.4M in the corresponding prior year period. The diluted income per share for the fourth quarter of 2022 was $ 10c, as compared to the diluted loss per share of 9c in the prior year period. "We are pleased with our strong performance in the fourth quarter and full year 2022. Our growth in the fourth quarter, as well as for the year, was primarily driven by higher utilization at existing centers and the addition of 61 newU.S. implanting centers and 16 new U.S. sales territories. With significant momentum and many accomplishments throughout our business, we are proud to achieve our first profitable quarter," said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems. "Given our strong performance in 2022, we are providing 2023 revenue guidance of between $560 million to $570 million, an increase of 37% to 40% year-over-year.""We completed several important milestones in 2022 including an expanded label for full-body MRI compatibility, the commercial launches of our Bluetooth(R)-enabled patient remote and our silicone-based stimulation and sensing leads, the FDA submission of our SleepSync programmer, and important indication expansions for Pediatric Down Syndrome and higher AHI and BMI. We completed enrollment of 300 patients in our PREDICTOR study which aims to remove the drug-induced sleep endoscopy requirement for most patients with BMI under 32. We also made strategic investments in EnsoData and Ognomy and initiated a pilot of a digital scheduling tool to facilitate and streamline patient access to care through our Advisor Care Program," concluded Mr. Herbert. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $249.92 / +6.5 (+2.67%) 12/20/22 Inspire Medical publishes inaugural ESG summary report 09/14/22 Inspire Medical announces updates from ISSS, AAO-HNSF meetings 08/15/22 Inspire Medical appoints Ezgi Yagci as VP, investor relations INSP Inspire Medical $249.92 / +6.5 (+2.67%) 01/31/23 Truist Inspire Medical price target raised to $310 from $308 at Truist 01/31/23 Lake Street CVRx initiated with a Buy at Lake Street 01/26/23 Piper Sandler Inspire Medical price target raised to $300 from $285 at Piper Sandler 12/13/22 Goldman Sachs Inspire Medical upgraded to Buy, named top Medtech midcap at Goldman Sachs INSP Inspire Medical $249.92 / +6.5 (+2.67%) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 11/01/22 Inspire Medical reports Q3 EPS (60c), consensus (77c) 12 Aug INSP Inspire Medical $249.92 / +6.5 (+2.67%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/07/23 Inspire Medical - INSP 03/01/23 Inspire Medical 03/02/23 Inspire Medical
On The Fly	Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:08 01/31/23 01/31 10:08 01/31/23 10:08 FLT FleetCor $203.84 / +2.75 (+1.37%) , FGEN FibroGen $22.62 / +1.01 (+4.67%) , LYB LyondellBasell $95.78 / +1.3 (+1.38%) , NFE New Fortress Energy $37.70 / +0.45 (+1.21%) , INTR Inter&Co $2.69 / +0.17 (+6.75%) , PARA Paramount $22.40 / -0.215 (-0.95%) , EW Edwards Lifesciences $76.00 / -0.125 (-0.16%) , MDT Medtronic $82.83 / +0.23 (+0.28%) , BAC Bank of America $35.13 / -0.18 (-0.51%) , TFC Truist Financial $48.38 / -0.06 (-0.12%) , NUS Nu Skin $41.52 / -0.78 (-1.84%) , META Meta Platforms $148.95 / +1.905 (+1.30%) , INCY Incyte $84.95 / +1.26 (+1.51%) , FOXA Fox Corp. $33.70 / +0.06 (+0.18%) , XMTR Xometry $33.99 / +1.28 (+3.91%) , CVRX CVRx $15.08 / +0.4 (+2.72%) , INSP Inspire Medical $256.10 / +5.41 (+2.16%) Institutional investors… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XMTR TFC PARA NUS NFE META MDT LYB INTR INSP INCY FOXA FLT FGEN EW CVRX BAC XMTR Xometry $33.99 / +1.28 (+3.91%) 11/02/22 Xometry CEO sells $1.2M in common stock 10/05/22 Xometry CEO sells $1.17M in common stock 10/03/22 Xometry appoints Matt Leibel as CTO, Brendan Sterne as CPO 08/25/22 Xometry, CCBC announce public-private partnership for two-year scholarships TFC Truist Financial $48.38 / -0.06 (-0.12%) 01/24/23 Truist Financial trading resumes 01/24/23 Truist Financial trading halted, volatility trading pause 12/14/22 Truist Financial raises prime rate to 7.5% from 7% 11/28/22 Main Street announces new $240M secured credit facility PARA Paramount $22.40 / -0.215 (-0.95%) 01/23/23 Association of Pickleball Professionals announces broadcast deals with CBS, ESPN 12/08/22 Paramount+ launches in Germany, Switzerland and Austria 12/07/22 Paramount CEO says view of 2023 as peak streaming investment year hasn't changed 12/06/22 Paramount CEO sees Q4 ad business 'a bit below' Q3 NUS Nu Skin $41.52 / -0.78 (-1.84%) 11/28/22 PBF Energy to replace Nu Skin in the S&P 400 at open on 12/1 NFE New Fortress Energy $37.70 / +0.45 (+1.21%) 01/25/23 New Fortress Energy unit wins contract to manage Puerto Rico power plants 01/03/23 Director of New Fortress Energy Wilkinson sells $454,348 in company shares 11/22/22 New Fortress Energy finalizes agreements with Pemex 10/28/22 New Fortress Energy finalizes agreement with Comision Federal de Electricidad META Meta Platforms $148.95 / +1.905 (+1.30%) 01/30/23 Instagram launches Notes in Europe and Japan 01/26/23 Privacy chief of Canada: Home Depot shared personal customer data with Meta 01/25/23 Meta ends suspension of Trump's Facebook, Instagram accounts 01/23/23 Meta expands partnership with NBA, WNBA as league's official VR headset MDT Medtronic $82.83 / +0.23 (+0.28%) 01/30/23 Medtronic recalls Hemodialysis Catheters for leaks, FDA says 01/27/23 Orchestra BioMed begins trading on Nasdaq with cash runway into 2026 01/25/23 Medtronic recommends rejection of below-market mini-tender by TRC Capital 01/09/23 Medtronic sees getting back to pre-Covid gross margin levels in 3-4 years LYB LyondellBasell $95.78 / +1.3 (+1.38%) 11/18/22 LyondellBasell moving forward with advanced recylicng plant in Germany 11/17/22 LyondellBasell evaluates propylene expansion project 10/20/22 LyondellBasell, Shakti Plastic sign MoU to operate recycling plant in India 10/19/22 Air Liquide, Chevron, others team team on hydrogen project along US Gulf Coast INTR Inter&Co $2.69 / +0.17 (+6.75%) 01/18/23 Inter&Co announces '60-30-30' long-term growth targets 11/29/22 Inter&Co joins Amazon's Payment Service Provider Program 09/16/22 Inter&Co rebrands its remittances business in U.S. INSP Inspire Medical $256.10 / +5.41 (+2.16%) 12/20/22 Inspire Medical publishes inaugural ESG summary report 09/14/22 Inspire Medical announces updates from ISSS, AAO-HNSF meetings 08/15/22 Inspire Medical appoints Ezgi Yagci as VP, investor relations 08/01/22 Inspire Medical appoints Cynthia Burks, Charisse Sparks to board INCY Incyte $84.95 / +1.26 (+1.51%) 12/11/22 Incyte's novel mutant CALR antibody unveiled at ASH 2022 12/05/22 Syndax, Incyte report axatilimab Phase 1/2 data 12/02/22 Incyte, CMS Aesthetics enter ruxolitinib collaboration and license agreement 11/07/22 Incyte, Mirati Therapeutics enter INCB99280 clinical trial and supply pact FOXA Fox Corp. $33.70 / +0.06 (+0.18%) 01/24/23 Irenic Capital comments on withdrawal of proposal to combine News Corp, Fox 01/24/23 Rupert Murdoch withdrawing proposal for Fox Corp, News Corp. combination 01/24/23 Rupert Murdoch withdraws proposal for Fox News, News Corp. tie-up 01/24/23 Rupert Murdoch withdrawing proposal for Fox Corp, News Corp. combination FLT FleetCor $203.84 / +2.75 (+1.37%) 10/20/22 FleetCor to acquire European workforce lodging provider Roomex 09/26/22 FleetCor CFO Freund to leave company 09/07/22 FleetCor signs network agreements with Exxon Mobil 09/06/22 FleetCor acquires Plugsurfing, terms not stated FGEN FibroGen $22.62 / +1.01 (+4.67%) 08/26/22 FibroGen announces completion of patient enrollment in MATTERHORN EW Edwards Lifesciences $76.00 / -0.125 (-0.16%) 12/08/22 Edwards Lifesciences CEO Michael Mussallem to retire, Bernard Zovighian succeeds 11/01/22 Edwards Lifesciences authorizes $750M accelerated share repurchase 10/28/22 Edwards Lifesciences falls -16.6% 10/28/22 Edwards Lifesciences falls -14.3% CVRX CVRx $15.08 / +0.4 (+2.72%) 11/03/22 CVRx announces launch of Barostim NEO2 IPG BAC Bank of America $35.13 / -0.18 (-0.51%) 01/13/23 Bank of America sees mid-single digit loan growth next year 01/13/23 Bank of America sees Q1 NII around $14.4B 01/13/23 Bank of America sees net charge-offs moving to pre-pandemic levels 01/13/23 Bank of America starting to see stabilization in deposits, says CEO FLT FGEN LYB NFE INTR PARA EW MDT BAC TFC NUS META INCY FOXA XMTR CVRX INSP FLT FleetCor $203.84 / +2.75 (+1.37%) 01/31/23 BofA FleetCor upgraded to Buy at BofA as risks get addressed 'head on' 01/31/23 BofA FleetCor upgraded to Buy from Neutral at BofA 01/25/23 Baird FleetCor price target raised to $230 from $220 at Baird 01/20/23 Truist Wex price target raised to $190 from $170 at Truist FGEN FibroGen $22.62 / +1.01 (+4.67%) 01/30/23 William Blair FibroGen upgraded to Outperform at William Blair on pamrevlumab's potential 01/30/23 William Blair FibroGen upgraded to Outperform from Market Perform at William Blair 01/26/23 Raymond James FibroGen upgraded to Outperform from Market Perform at Raymond James 01/26/23 Raymond James FibroGen upgraded to Outperform from Market Perform at Raymond James LYB LyondellBasell $95.78 / +1.3 (+1.38%) 01/31/23 Atlantic Equities LyondellBasell upgraded to Overweight from Neutral at Atlantic Equities 01/17/23 Fermium Research LyondellBasell downgraded to Hold from Buy at Fermium Research 01/17/23 Fermium Research Dow Inc. downgraded to Hold from Buy at Fermium Research 01/12/23 KeyBanc LyondellBasell price target raised to $83 from $65 at KeyBanc NFE New Fortress Energy $37.70 / +0.45 (+1.21%) 01/31/23 BTIG New Fortress Energy upgraded to Buy from Neutral at BTIG 11/16/22 Barclays New Fortress Energy price target raised to $53 from $48 at Barclays 10/19/22 Jefferies New Fortress Energy initiated with a Buy at Jefferies 10/19/22 Barclays New Fortress Energy price target lowered to $48 from $54 at Barclays INTR Inter&Co $2.69 / +0.17 (+6.75%) 01/31/23 Goldman Sachs Inter&Co upgraded to Buy from Neutral at Goldman Sachs 12/08/22 Grupo Santander Inter&Co downgraded to Neutral from Outperform at Grupo Santander 09/06/22 Goldman Sachs Inter&Co upgraded to Neutral from Sell at Goldman Sachs 07/06/22 New Street Inter&Co initiated with a Neutral at New Street after listing moved to U.S. PARA Paramount $22.40 / -0.215 (-0.95%) 01/31/23 Macquarie Paramount downgraded to Underperform at Macquarie on high ad exposure 01/31/23 Macquarie Paramount downgraded to Underperform from Neutral at Macquarie 01/12/23 Guggenheim Paramount price target raised to $22 from $20 at Guggenheim 01/04/23 Macquarie Paramount price target lowered to $15 from $16 at Macquarie EW Edwards Lifesciences $76.00 / -0.125 (-0.16%) 01/31/23 Bernstein Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein 01/30/23 Piper Sandler Edwards Lifesciences downgraded to Neutral from Overweight at Piper Sandler 12/12/22 Canaccord Edwards Lifesciences price target lowered to $73 from $78 at Canaccord 12/12/22 Citi Edwards Lifesciences price target lowered to $92 from $99 at Citi MDT Medtronic $82.83 / +0.23 (+0.28%) 01/24/23 Mizuho Medtronic price target lowered to $95 from $100 at Mizuho 01/09/23 RBC Capital Medtronic downgraded to Sector Perform from Outperform at RBC Capital 11/30/22 Wells Fargo Medtronic price target lowered to $77 from $82 at Wells Fargo BAC Bank of America $35.13 / -0.18 (-0.51%) 01/31/23 Atlantic Equities Bank of America downgraded to Neutral from Overweight at Atlantic Equities 01/24/23 BofA Banks' potential new online wallet unlikely to threaten PayPal, says BofA 01/17/23 Citi Bank of America price target raised to $38 from $36 at Citi 01/17/23 Piper Sandler Bank of America downgraded to Underweight from Neutral at Piper Sandler TFC Truist Financial $48.38 / -0.06 (-0.12%) 01/31/23 Stephens Truist Financial downgraded to Equal Weight at Stephens following outperformance 01/31/23 Stephens Truist Financial downgraded to Equal Weight from Overweight at Stephens 01/09/23 Jefferies Truist Financial upgraded to Buy from Hold at Jefferies 01/06/23 Deutsche Bank Truist downgraded to Hold with $48 target at Deutsche Bank NUS Nu Skin $41.52 / -0.78 (-1.84%) 01/31/23 Jefferies Nu Skin downgraded to Hold at Jefferies on China execution uncertainty 01/30/23 Jefferies Nu Skin downgraded to Hold from Buy at Jefferies 12/20/22 DA Davidson Nu Skin price target raised to $40 from $34 at DA Davidson 11/23/22 DA Davidson Nu Skin price target lowered to $34 from $40 at DA Davidson META Meta Platforms $148.95 / +1.905 (+1.30%) 01/31/23 LightShed Partners Meta Platforms initiated with a Buy at LightShed Partners 01/30/23 DA Davidson DA Davidson neutral on Pinterest ahead of earnings 01/27/23 BofA BuzzFeed still a 'show me story,' Meta deal not new, says BofA 01/26/23 Piper Sandler Meta Platforms price target raised to $136 from $116 at Piper Sandler INCY Incyte $84.95 / +1.26 (+1.51%) 01/31/23 Piper Sandler Incyte initiated with an Overweight at Piper Sandler 10/24/22 JPMorgan Incyte price target lowered to $80 from $86 at JPMorgan 08/03/22 Evercore ISI Incyte downgraded to In Line from Outperform at Evercore ISI 08/03/22 Guggenheim Incyte downgraded to Neutral at Guggenheim after Opzelura Q2 miss FOXA Fox Corp. $33.70 / +0.06 (+0.18%) 01/31/23 Morgan Stanley Fox Corp. resumed with an Equal Weight at Morgan Stanley 01/25/23 Loop Capital Fox upgraded to Buy with $40 price target at Loop Capital 01/25/23 Loop Capital Loop upgrades News Corp. to Buy on ending of Fox tie-up 01/25/23 Loop Capital Fox Corp. upgraded to Buy from Hold at Loop Capital XMTR Xometry $33.99 / +1.28 (+3.91%) 01/31/23 Craig-Hallum Xometry initiated with a Buy at Craig-Hallum 12/14/22 Lake Street Xometry initiated with a Sell at Lake Street 12/13/22 Citi Xometry initiated with a Buy at Citi 11/11/22 UBS Xometry price target lowered to $45 from $55 at UBS CVRX CVRx $15.08 / +0.4 (+2.72%) 01/31/23 Lake Street CVRx initiated with a Buy at Lake Street 01/27/23 Canaccord CVRx price target lowered to $22 from $23 at Canaccord 01/09/23 Piper Sandler CVRx price target raised to $18.50 from $14 at Piper Sandler 11/02/22 Piper Sandler CVRx price target raised to $14 from $10 at Piper Sandler INSP Inspire Medical $256.10 / +5.41 (+2.16%) 01/31/23 Truist Inspire Medical price target raised to $310 from $308 at Truist 01/26/23 Piper Sandler Inspire Medical price target raised to $300 from $285 at Piper Sandler 12/13/22 Goldman Sachs Inspire Medical upgraded to Buy, named top Medtech midcap at Goldman Sachs XMTR TFC PARA NUS NFE META MDT LYB INSP INCY FOXA FLT FGEN EW CVRX BAC XMTR Xometry $33.99 / +1.28 (+3.91%) 11/10/22 Xometry sees Q4 revenue $104M-$106M, consensus $116.11M 11/10/22 Xometry reports Q3 adjusted EPS (11c), consensus (22c) 08/10/22 Xometry sees 2022 revenue $395M-$400M, consensus $397.09M 08/10/22 Xometry sees Q3 revenue $102M-$104M, consensus $103.9M TFC Truist Financial $48.38 / -0.06 (-0.12%) 01/19/23 Truist Financial reports Q4 adjusted EPS $1.30, consensus $1.28 01/18/23 Notable companies reporting before tomorrow's open 10/18/22 Truist Financial reports Q3 adjusted EPS $1.24, consensus $1.24 PARA Paramount $22.40 / -0.215 (-0.95%) 11/02/22 Paramount reports Q3 adjusted EPS 39c, consensus 43c 11/01/22 Notable companies reporting before tomorrow's open 08/04/22 Paramount reports Q2 EPS 53c, consensus 62c NUS Nu Skin $41.52 / -0.78 (-1.84%) 11/02/22 Nu Skin sees 2022 EPS $2.40-$2.60, consensus $3.34 11/02/22 Nu Skin sees Q4 non-GAAP EPS 40c-60c, consensus $1.09 11/02/22 Nu Skin reports Q3 adjusted EPS 47c, consensus 78c 11/02/22 Nu Skin reports Q3 adjusted EPS 47c, consensus 78c NFE New Fortress Energy $37.70 / +0.45 (+1.21%) 11/08/22 New Fortress Energy reports Q3 EPS 41c, consensus 80c 08/04/22 New Fortress Energy reports Q2 adjusted EPS 69c, consensus 50c META Meta Platforms $148.95 / +1.905 (+1.30%) 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B 10/26/22 Meta Platforms sees Q4 revenue $30B-$32.5B, consensus $32.31B 10/26/22 Meta Platforms reports Q3 EPS $1.64, consensus $1.89 10/26/22 Notable companies reporting after market close MDT Medtronic $82.83 / +0.23 (+0.28%) 11/22/22 Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40 11/22/22 Medtronic says guidance assumes 2H23 reported revenue $15.4B-$15.6B 11/22/22 Medtronic cuts FY23 EPS view to $5.25-$5.30 from $5.53-$5.65, consensus $5.53 11/22/22 Medtronic reports Q2 EPS $1.30, consensus $1.28 LYB LyondellBasell $95.78 / +1.3 (+1.38%) 10/28/22 LyondellBasell reports Q3 adjusted EPS $1.96, consensus $2.84 INSP Inspire Medical $256.10 / +5.41 (+2.16%) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 11/01/22 Inspire Medical reports Q3 EPS (60c), consensus (77c) INCY Incyte $84.95 / +1.26 (+1.51%) 11/01/22 Incyte reports Q3 EPS 60c, consensus 72c 08/02/22 Incyte reports Q2 EPS $1.01, consensus 76c FOXA Fox Corp. $33.70 / +0.06 (+0.18%) 11/01/22 Fox Corp. reports Q1 adjusted EPS $1.21, consensus $1.14 10/31/22 Notable companies reporting before tomorrow's open 08/10/22 Fox Corp. reports Q4 adjusted EPS 74c, consensus 76c FLT FleetCor $203.84 / +2.75 (+1.37%) 11/02/22 FleetCor reaffirms FY22 adjusted EPS view $15.85-$16.05, consensus $15.97 11/02/22 FleetCor reports Q3 adjusted EPS $4.24 consensus $4.18 09/26/22 FleetCor sees Q3 results at least in line with previously provided outlook 08/03/22 FleetCor raises FY22 adjusted EPS view to $15.85-$16.05, consensus $15.51 FGEN FibroGen $22.62 / +1.01 (+4.67%) 11/07/22 FibroGen reports Q3 EPS (98c), consensus (81c) 08/08/22 FibroGen reports Q2 EPS (78c), consensus (94c) EW Edwards Lifesciences $76.00 / -0.125 (-0.16%) 01/10/23 Edwards Lifesciences not reaffirming Q4, 2023 guidance 12/08/22 Edwards Lifesciences backs FY22 adjusted EPS view $2.40-$2.50, consensus $2.46 12/08/22 Edwards Lifesciences sees FY23 adjusted EPS $2.45-$2.60, consensus $2.53 10/27/22 Edwards Lifesciences sees FY22 adjusted EPS $2.40-$2.50, consensus $2.51 CVRX CVRx $15.08 / +0.4 (+2.72%) 01/26/23 CVRx sees FY23 revenue $35M-$38M, consensus $37.03M 01/26/23 CVRx sees Q1 revenue $7.1M-$7.5M, consensus $7.42M 01/26/23 CVRx reports Q4 EPS (51c), consensus (56c) 01/09/23 CVRx sees FY23 revenue $35M-$38M, consensus $38M BAC Bank of America $35.13 / -0.18 (-0.51%) 01/13/23 Bank of America reports Q4 EPS 85c, consensus 77c 01/12/23 Notable companies reporting before tomorrow's open 10/17/22 Bank of America reports Q3 EPS 81c, consensus 77c 15 Dec 12 Aug XMTR TFC PARA NFE META MDT FOXA BAC XMTR Xometry $33.99 / +1.28 (+3.91%) 01/24/23 Culper goes short Xometry, says 'misleads investors' about business 01/24/23 Culper says short Xometry, says recurring revenue narrative 'bogus' TFC Truist Financial $48.38 / -0.06 (-0.12%) 10/29/22 Truist among dividend-paying stocks to help battle inflation, Barron's says 09/18/22 Big regional banks might face new crisis rules, WJS reports PARA Paramount $22.40 / -0.215 (-0.95%) 01/24/23 Paramount may add Paramount+ content to Showtime TV channel, WSJ says 01/13/23 YouTube testing new hub of free, ad-supported streaming channels, WSJ reports 01/10/23 Paramount+ orders live-action show based on 'Dungeons & Dragons,' TC says 01/05/23 Paramount sued by 'Romeo and Juliet' stars, WSJ reports NFE New Fortress Energy $37.70 / +0.45 (+1.21%) 10/14/22 U.K. in talks with U.S. LNG producers over purchase agreements, Sky News says META Meta Platforms $148.95 / +1.905 (+1.30%) 01/31/23 Reels sharing revenue with creators hotly debated within Meta, Information says 01/27/23 Meta starting to see recovery path after Apple changes, WSJ reports 01/26/23 Morgan Stanley penalizes staff over WhatsApp breaches, Reuters reports 01/26/23 Meta paying BuzzFed to generate creator content for Facebook, IG, WSJ reports MDT Medtronic $82.83 / +0.23 (+0.28%) 12/17/22 Amazon, Google among Barron's 10 favorite stocks for 2023 12/15/22 GE among companies studying Medtronic businesses, Bloomberg reports FOXA Fox Corp. $33.70 / +0.06 (+0.18%) 01/31/23 Warner Bros. Discovery in deals with Roku, Tubi for FAST channels, Reuters says 01/24/23 News Corp. in discussions to sell 80% Move stake to CoStar, FT reports 01/04/23 Fox Corp., News Corp. renew office leases in Manhattan, WSJ reports BAC Bank of America $35.13 / -0.18 (-0.51%) 01/23/23 Banks teaming up to launch digital wallet to compete with PayPal, WSJ reports 01/17/23 Hsu says some big banks could face breakup, WSJ reports 12/09/22 BofA CEO Moynihan on short list to replace Yellen, Gaparino says via Twitter XMTR TFC PARA NFE META MDT LYB INCY FOXA FLT FGEN EW BAC XMTR Xometry $33.99 / +1.28 (+3.91%) 01/24/23 What You Missed On Wall Street This Morning 01/13/23 Sell these stocks now, proven algorithm says 12/16/22 Sell these stocks now, proven algorithm says TFC Truist Financial $48.38 / -0.06 (-0.12%) 09/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/19/22 What You Missed On Wall Street On Monday 09/19/22 What You Missed On Wall Street This Morning PARA Paramount $22.40 / -0.215 (-0.95%) 01/29/23 Box Office Battle: ‘Avatar 2’ stays atop chart in seventh weekend 01/25/23 Here's what Wall St. experts are saying about these media names ahead of results 01/24/23 What You Missed On Wall Street On Tuesday 01/22/23 Box Office Battle: ‘Avatar 2’ wins weekend, crosses $2B globally NFE New Fortress Energy $37.70 / +0.45 (+1.21%) 12/15/22 What You Missed On Wall Street On Thursday 12/15/22 What You Missed On Wall Street This Morning 12/14/22 Fly Intel: After-Hours Movers 11/08/22 Fly Intel: Pre-market Movers META Meta Platforms $148.95 / +1.905 (+1.30%) 01/27/23 What You Missed On Wall Street On Friday 01/27/23 What You Missed On Wall Street This Morning MDT Medtronic $82.83 / +0.23 (+0.28%) 12/19/22 Fly Insider: Willdan Group, Medtronic among weeks' notable insider transactions 11/23/22 What You Missed On Wall Street On Wednesday 11/23/22 What You Missed On Wall Street This Morning 11/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations LYB LyondellBasell $95.78 / +1.3 (+1.38%) 10/28/22 Fly Intel: Pre-market Movers 09/02/22 What You Missed On Wall Street On Friday 09/02/22 What You Missed On Wall Street This Morning 09/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations INCY Incyte $84.95 / +1.26 (+1.51%) 08/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations FOXA Fox Corp. $33.70 / +0.06 (+0.18%) 01/25/23 What You Missed On Wall Street On Wednesday 01/25/23 What You Missed On Wall Street This Morning 01/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/24/23 Fly Intel: After-Hours Movers FLT FleetCor $203.84 / +2.75 (+1.37%) 10/20/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/27/22 What You Missed On Wall Street This Morning FGEN FibroGen $22.62 / +1.01 (+4.67%) 01/26/23 What You Missed On Wall Street On Thursday 01/26/23 What You Missed On Wall Street This Morning 01/26/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/09/23 Biotech Alert: Searches spiking for these stocks today EW Edwards Lifesciences $76.00 / -0.125 (-0.16%) 12/08/22 What You Missed On Wall Street On Thursday 12/08/22 What You Missed On Wall Street This Morning 12/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/28/22 What You Missed On Wall Street On Friday BAC Bank of America $35.13 / -0.18 (-0.51%) 01/23/23 What You Missed On Wall Street On Monday 01/23/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street On Friday 01/13/23 What You Missed On Wall Street This Morning 02/16/23 MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference 02/24/23 Annual Meeting of AAAAI 2023 02/25/23 16th Int'l Conference on Advanced Technologies & Treatments for Diabetes (ATTD) 03/21/23 6th Annual Consumer Growth Conference 03/22/23 7th Annual LNG Bus Tour 01/31/23 Edwards Lifesciences - EW 02/01/23 Meta Platforms - META 02/03/23 LyondellBasell - LYB 02/07/23 Incyte - INCY 02/07/23 Inspire Medical - INSP 02/08/23 Fox Corp. - FOXA 02/08/23 FleetCor - FLT 02/15/23 Nu Skin - NUS 02/16/23 Paramount - PARA 02/21/23 Medtronic - MDT 04/18/23 Bank of America - BAC 04/20/23 Truist Financial - TFC 00:00 Today PDUFA Date for QD Ruxolitinib ER 03/01/23 Inspire Medical 03/02/23 Inspire Medical TFC PARA NFE META MDT LYB INTR INCY FOXA EW BAC TFC Truist Financial $48.38 / -0.06 (-0.12%) 01/19/23 Early notable gainers among liquid option names on January 19th PARA Paramount $22.40 / -0.215 (-0.95%) 01/23/23 Paramount Global call volume above normal and directionally bullish 01/04/23 Heavy put volume in Paramount Global 01/03/23 Early notable gainers among liquid option names on January 3rd 12/27/22 Paramount Global call volume above normal and directionally bullish NFE New Fortress Energy $37.70 / +0.45 (+1.21%) 11/07/22 New Fortress Energy options imply 9.4% move in share price post-earnings 11/02/22 Largest borrow rate increases among liquid names META Meta Platforms $148.95 / +1.905 (+1.30%) 01/10/23 Notable open interest changes for January 10th 01/04/23 Meta Platforms (Facebook) call volume above normal and directionally bullish 12/16/22 Early notable gainers among liquid option names on December 16th 12/02/22 Notable open interest changes for December 2nd MDT Medtronic $82.83 / +0.23 (+0.28%) 01/09/23 Medtronic put volume heavy and directionally bearish 11/21/22 Early notable gainers among liquid option names on November 21st 11/04/22 Medtronic call volume above normal and directionally bullish 09/19/22 Medtronic put volume heavy and directionally bearish LYB LyondellBasell $95.78 / +1.3 (+1.38%) 11/22/22 Early notable gainers among liquid option names on November 22nd INTR Inter&Co $2.69 / +0.17 (+6.75%) 09/28/22 Fifteen new option listings and one option delisting on September 28th INCY Incyte $84.95 / +1.26 (+1.51%) 11/01/22 Early notable gainers among liquid option names on November 1st FOXA Fox Corp. $33.70 / +0.06 (+0.18%) 01/25/23 Early notable gainers among liquid option names on January 25th EW Edwards Lifesciences $76.00 / -0.125 (-0.16%) 12/05/22 Edwards Lifesciences call volume above normal and directionally bullish 10/31/22 Early notable gainers among liquid option names on October 31st 10/27/22 Edwards Lifesciences options imply 4.1% move in share price post-earnings 10/12/22 Early notable gainers among liquid option names on October 12th BAC Bank of America $35.13 / -0.18 (-0.51%) 01/03/23 Bank of America call volume above normal and directionally bullish 12/07/22 Notable open interest changes for December 7th 12/06/22 Notable open interest changes for December 6th 11/07/22 Bank of America call volume above normal and directionally bullish
Recommendations	Inspire Medical price target raised to $310 from $308 at Truist » 09:12 01/31/23 01/31 09:12 01/31/23 09:12 INSP Inspire Medical $250.95 / -2.8 (-1.10%) Truist analyst Richard… Truist analyst Richard Newitter raised the firm's price target on Inspire Medical to $310 from $308 and keeps a Buy rating on the shares a part of a broader research note previewing Q4 earnings in MedTech. The stock is the firm's "highest conviction beat and raise" forecast after the company pre-announced Q4 revenue last month and as its U.S. monthly utilization again accelerated, the analyst tells investors in a research note. As long as Inspire's growth remains on an accelerating trajectory, the stock's multiple can be sustained with estimates that have big upward revision potential, Truist adds. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events INSP Inspire Medical $250.95 / -2.8 (-1.10%) 12/20/22 Inspire Medical publishes inaugural ESG summary report 09/14/22 Inspire Medical announces updates from ISSS, AAO-HNSF meetings 08/15/22 Inspire Medical appoints Ezgi Yagci as VP, investor relations 08/01/22 Inspire Medical appoints Cynthia Burks, Charisse Sparks to board INSP Inspire Medical $250.95 / -2.8 (-1.10%) 01/31/23 Lake Street CVRx initiated with a Buy at Lake Street 01/26/23 Piper Sandler Inspire Medical price target raised to $300 from $285 at Piper Sandler 12/13/22 Goldman Sachs Inspire Medical upgraded to Buy, named top Medtech midcap at Goldman Sachs 12/13/22 Goldman Sachs Inspire Medical upgraded to Buy from Neutral at Goldman Sachs INSP Inspire Medical $250.95 / -2.8 (-1.10%) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 11/01/22 Inspire Medical reports Q3 EPS (60c), consensus (77c) 12 Aug 02/07/23 Inspire Medical - INSP 03/01/23 Inspire Medical 03/02/23 Inspire Medical

On The Fly

News and insights, exclusive to thefly.com

12:12	What You Missed On Wall Street This Morning»
11:06	Biotech Alert: Searches spiking for these stocks today»
10:56	Here's What You Missed in Cannabis, Psychedelics This Week»
09:59	Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations»
09:12	Fly Intel: Pre-market Movers»

View all On The Fly Stories »

Upcoming
Events (10)

INCY	PDUFA Date for QD Ruxolitinib ER
DCOM	Dime Community - DCOM
	Game Developers Conference
	Adobe Summit
MMM ...	Global Industrials Conference
	7th Annual LNG Bus Tour
	Applied Power Electronics Conference
	India IT Services Trip
	March Small-Cap Virtual Conference
NPIFF	Northland Power

View all of today’s events »

Today’s
Syndicate (1)

BANL	IPO

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial